 | Up a level |
Journal Article
Neuhann, Julia M. 
ORCID: 0000-0003-4479-6322, Stemler, Jannik ORCID: 0000-0001-9152-2469, Carcas, Antonio ORCID: 0000-0003-1823-4174, Frías-Iniesta, Jesús ORCID: 0000-0001-9538-9677, Bethe, Ullrich ORCID: 0000-0001-9979-1671, Heringer, Sarah ORCID: 0000-0001-7680-0344, Tischmann, Lea ORCID: 0000-0003-0178-0670, Zarrouk, Marouan ORCID: 0000-0002-3259-6123, Cüppers, Arnd ORCID: 0000-0001-8971-9481, König, Franz ORCID: 0000-0002-6893-3304, Posch, Martin ORCID: 0000-0001-8499-8573 and Cornely, Oliver A. ORCID: 0000-0001-9599-3137
(2022).
A multinational, phase 2, randomised, adaptive protocol to evaluate immunogenicity and reactogenicity of different COVID-19 vaccines in adults ≥75 already vaccinated against SARS-CoV-2 (EU-COVAT-1-AGED): a trial conducted within the VACCELERATE network.
Trials, 23 (1).
p. 865.
Springer Nature.
ISSN 1745-6215
